Teknova
5 articles about Teknova
-
Teknova to Participate in Upcoming June 2023 Investor Conference
5/25/2023
Alpha Teknova, Inc. announced that the Company will present and host individual and small group meetings at the following upcoming investor conference:
-
Teknova Reports Third Quarter 2022 Financial Results
11/9/2022
Alpha Teknova, Inc., a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, announced financial results for the third quarter ended September 30, 2022.
-
Teknova to Report Third Quarter 2021 Financial Results on November 10, 2021
11/3/2021
Alpha Teknova, Inc., a leading provider of critical reagents for the development and production of biopharmaceutical products including drug therapies, novel vaccines, and molecular diagnostics, announced that it will report its financial results for the third quarter of 2021 on Wednesday, November 10, 2021, following the close of market.
-
Teknova Appoints Matt Lowell as CFO to Help the Company Achieve Long-term Strategic Goals
5/6/2021
Teknova , a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, announced today that Matt Lowell has joined the company as Chief Financial Officer (CFO). Lowell brings with him nearly 20 years of financial and strategic leadership experience
-
Teknova Welcomes Stephen Gunstream as CEO
6/25/2020
Teknova , a leading ISO 13485-certified manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, is pleased to announce the appointment of Stephen Gunstream as chief executive officer. Stephen has nearly 20 years of experience i